Clinical Trials Browser

Phase 1/2 × Advanced Non-small Cell Lung Cancer (NSCLC) × 90 days × Clear all

NCT07590531 2026-05-15

AMT-116 in Combination With Ivosidan in Patients With Lung Cancer

Phase 1/2 Not yet recruiting

Advanced Non-small Cell Lung Cancer (NSCLC)